Status:
COMPLETED
HLA-DR Expression in Neonates After Cardiac Surgery Under Cardiopulmonary Bypass
Lead Sponsor:
Nantes University Hospital
Collaborating Sponsors:
Fédération Française de Cardiologie
Conditions:
Cardiac Surgery
Eligibility:
All Genders
Up to 28 years
Brief Summary
The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in neonates who underwent cardiac surgery with cardiopulmonary bypasss. We hypothes...
Eligibility Criteria
Inclusion
- Patients aged ≤ 28 days
- Admission after cardiac surgery under cardiopulmonary bypass
Exclusion
- Lack of parental consent
Key Trial Info
Start Date :
January 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 13 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03309839
Start Date
January 29 2018
End Date
April 13 2019
Last Update
September 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France, 44093